Aravind R. Sanjeevaiah, M.D.
Medical Oncology Physician · Waxahachie, TX
Aravind R. Sanjeevaiah, M.D. is a medical oncology physician with a practice address in Waxahachie, Texas, and NPI 1093913196, issued on Jul 10, 2007. Check the license (Texas Q5924, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Aravind R. Sanjeevaiah
- Credential
- M.D.
- Primary taxonomy
- Medical Oncology Physician 207RX0202X
- License number
- Q5924 TX
Self-reported in NPPES; status is on the state search - Practice location
- 2380 S. I-35E, Waxahachie, TX 75165
- Phone
- (469) 843-6000
- Enumerated
- Jul 10, 2007
- Record last updated
- Jun 5, 2024
- Medicare enrollment
- Enrolled (PECOS I20131025001490); accepts Medicare assignment
- Entity
- Type 1 · individual
8 nearest medical oncology physician records → All 547 in Texas → Look up another NPI →
Also registered at 2380 S. I-35E
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Michal Wolski, MDRadiation Oncology Physician1003001462
Verify Aravind R. Sanjeevaiah in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license Q5924Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
66% more Medicare Part D claims than the average medical oncology physician in 2024
1,164 Medicare Part D claims for 188 beneficiaries, against an average of 703 among the 4,230 providers of this specialty who prescribed in Part D. Brand-name drugs were 20% of claims. 182 claims were for opioids.
Most prescribed
- Ondansetron Hcl126 claims
- Eliquis115 claims
- Hydrocodone-Acetaminophen108 claims
- Dexamethasone84 claims
- Letrozole74 claims
- Lidocaine-Prilocaine60 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $210.28
6 payments; by number, the most common kind was food and beverage; the largest payer was Sumitomo Pharma America, Inc. The 3,343 providers of this specialty with any payment received $11,773.47 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Healthtexas Provider NetworkWaxahachie, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Aravind R. Sanjeevaiah among 547 medical oncology physician records in Texas
Aravind R. Sanjeevaiah, M.D. is one of 547 medical oncology physician records with a practice address in Texas. 85% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2007, is newer than 55% of them.
- NPI issued2007 · 55% of these records are older, 34% newer
- In a Medicare fileYes · 85% of these records are
- In the CMS Doctors and Clinicians fileYes · 76% of these records are
- Graduated2004 · median 2000 among the 414 with a school on file
- Record last updated2024 · 62% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RX0202X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Medical Oncology Physician providers in Texas
There are 547 medical oncology physician records in Texas.
All 547 in Texas → Every provider in Waxahachie → Medical Oncology Physician nationwide →
The 8 medical oncology physician records with the nearest ZIP codes
- Stephen Boswank, M.D.Mesquite, TX 751501346287992
- Shiela Haffar, M.D.Mesquite, TX 751501720010507
- Victor Horadam, M.D.Mesquite, TX 751501881636991
- Sudha Teerdhala, MDMesquite, TX 751501700828548
- Anita Tharian, DOMesquite, TX 751501457367112
- Maria Juarez, M. D.Duncanville, TX 751371447297965
- Edward Middleman, M. D.Duncanville, TX 751371972540623
- Maryada Reddy, M. D.Duncanville, TX 751371255370201
Common questions
What is Aravind R. Sanjeevaiah, M.D.'s NPI number?
Aravind R. Sanjeevaiah, M.D.'s National Provider Identifier (NPI) is 1093913196, issued on Jul 10, 2007. An NPI identifies a provider in billing; it is not a license.
Where is Aravind R. Sanjeevaiah, M.D. located?
The NPPES record lists a practice address at 2380 S. I-35E, Waxahachie, TX, 75165. Phone: (469) 843-6000. Providers update this record themselves, so call before visiting.
How can I verify Aravind R. Sanjeevaiah, M.D.'s license?
NPPES lists Texas license number Q5924, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Aravind R. Sanjeevaiah, M.D. prescribe under Medicare Part D?
In 2024, Aravind R. Sanjeevaiah, M.D. had 1,164 Medicare Part D claims for 188 beneficiaries; the average among medical oncology physician prescribers was 703. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.